Novo Nordisk cuts 450 positions in the US

Novo Nordisk cuts 450 positions in the US based on a desire to "ensure long-term sustainable growth on the US market". The exact amount of people being fired is still unclear.

Photo: Novo Nordisk / PR

Next year, 2021, will see 450 fewer jobs at Novo Nordisk's US subsidiary Novo Nordisk Inc., which employs 4,200 personnel in total, MedWatch gathers. Novo Nordisk confirms the information.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs